Related Experiment Videos
Neonatal cerebral hypoxia-ischemia: the effect of adenosine receptor antagonists
1Department of Anatomy and Cell biology, University of Göteborg, Sweden. elsa.bona@anatcell.gu.se
Abstract:
The effects of nonselective (theophylline), A1-(DPCPX) or A2A-selective (SCH 58261) adenosine receptor antagonists administered before or after neonatal hypoxia-ischemia (HI) were studied on the extent of brain injury in 7-day-old rats evaluated after 14 days. A possible effect of theophylline (20 mg/kg) on expression of immediate early genes was studied with in situ hybridization. Theophylline (20, 30 or 60 mg/kg) given prior to HI reduced brain damage by 48% (P < 0.001), 36% (P < 0.01) and 34% (P < 0.05), respectively, compared to control rats. This effect was not explained by changes in temperature, cerebral blood flow, blood gas/acid base status or blood glucose during the insult. Theophylline enhanced the upregulation of c-fos and NFGI-A during reperfusion but did not prevent the decrease in adenosine A1 receptor mRNA. Posttreatment with SCH 58261 (0.2 or 2 mg/kg) reduced brain damage by 19% (P < 0.05) and 14% (NS), respectively, compared to control rats which was unrelated to the core temperature. DPCPX (2 or 10 mg/kg) had no effect on the development of brain injury. In conclusion, nonselective and A2A adenosine receptor antagonists reduced brain injury in a model of HI in immature animals.
Insights
Nonselective and A2A adenosine receptor antagonists reduced brain injury in neonatal rats after hypoxia-ischemia (HI). Theophylline, a nonselective antagonist, significantly decreased brain damage when given before HI.
Area of Science:
- Neuroscience
- Pharmacology
- Neonatal research
Background:
- Neonatal hypoxia-ischemia (HI) is a major cause of brain injury in newborns.
- Adenosine receptors play a role in regulating brain function and injury response.
- Understanding the therapeutic potential of adenosine receptor antagonists is crucial for developing neuroprotective strategies.
Purpose of the Study:
- To investigate the neuroprotective effects of nonselective and selective adenosine receptor antagonists on brain injury following neonatal HI.
- To determine if theophylline, an adenosine receptor antagonist, influences immediate early gene expression after HI.
Main Methods:
- Neonatal rats (7-day-old) were subjected to a hypoxia-ischemia (HI) model.
- Adenosine receptor antagonists (theophylline, DPCPX, SCH 58261) were administered before or after HI.
- Brain injury was assessed after 14 days.
- In situ hybridization was used to study gene expression.
Main Results:
- Theophylline administered before HI significantly reduced brain damage in a dose-dependent manner.
- Post-treatment with SCH 58261 (A2A antagonist) also reduced brain injury.
- DPCPX (A1 antagonist) had no significant effect on brain injury.
- Theophylline enhanced c-fos and NFGI-A upregulation during reperfusion.
Conclusions:
- Nonselective and A2A adenosine receptor antagonists demonstrate neuroprotective effects in a neonatal HI model.
- Theophylline's protective effects are not mediated by changes in temperature, blood flow, or blood gases.
- Targeting adenosine A2A receptors may be a viable therapeutic strategy for neonatal brain injury.